Revatio Articles
NexMed's Befar launched in Hong Kong
29 April 2002
Pfizer 1st-qtr EPS increases 18%
22 April 2002
Legal dispute in India over sildenafil
22 April 2002
MUSE sales on the up at Vivus
25 March 2002
Australia "no" to Viagra PBS listing
18 February 2002
EMEA accepts Bayer's vardenafil dossier
4 February 2002
UK court rejects Pfizer appeal on PDE patent
28 January 2002
Australian PBS "should cover Viagra"
28 January 2002
VIVUS gets OK to test oral impotence drug
28 January 2002
First pivotal data on Bayer's vardenafil
13 December 2001
VIVUS pulls Alibra application in Europe
22 November 2001
Bayer reports heavy loss as impact of Baycol withdrawal takes hold
15 November 2001
New data on Viagra's looming competitors
4 October 2001
Viagra, a best-seller for Pfizer Malaysia
28 September 2001
Bayer files for approval of ED drug in USA
26 September 2001
Bayer files for approval of ED drug in USA
25 September 2001
MacroChem's Topiglan for ED clears Ph III trial
6 September 2001
Lilly ICOS' Cialis NDA accepted by FDA
3 September 2001
Web sites advocate pill-splitting to cut drug costs
2 August 2001
Pfizer loses PDE inhibitor patent
26 July 2001
Update - Pfizer second-quarter net income leaps 31%
18 July 2001
HMOs "do not have to fund Viagra:" US judge
11 July 2001
Lilly ICOS asks for FDA OK for Cialis
29 June 2001
Pfizer sues Cipla over Viagra trade mark
27 June 2001
Lilly ICOS' Cialis shows little effect in women
18 June 2001
Capturing unexpected benefits of research
6 June 2001
Cialis offers 24-hour activity in impotence
2 May 2001
Pfizer 1st-qtr 2001 net income rises 34%
23 April 2001
S-P takes Australian PBAC to court
23 March 2001
Cialis shows mettle as Viagra rival
20 March 2001
Viagra safety under review
15 March 2001
Vivus licenses MED drug from Tanabe
8 March 2001
US employers view staff drug benefits
18 January 2001
Vivus' Actis cleared for OTC use
2 January 2001
Vaccines acquisition set to drive near-term growth at PowderJect
12 December 2000
Ranbaxy seeks ED drug launch in India
24 November 2000
Stock Commentary - Tokyo
16 November 2000
Pfizer loses Viagra patent in UK
9 November 2000
New market forecasts to 2009 from DR
3 November 2000
India approves Pfizer's Viagra
25 October 2000
Vivus falls on withdrawal of Alibra NDA for impotence
24 October 2000
Pfizer finds no safety issues with Viagra
10 October 2000
$85 million Viagra lawsuit dismissed
22 September 2000
On-line pharmacies settle FTC charges
14 July 2000
Pfizer leads 1st-qtr US physician detailing
11 July 2000
Viagra on sale in China from next month
5 July 2000
Bayer sees potential in Viagra rival
2 June 2000
Viagra safe for stable heart disease patients
2 June 2000
US legislators slam pharma's "Viagra" year
10 May 2000
Pfizer developing inhalable Viagra
3 April 2000
Australian PMA views PBS Viagra decision
24 March 2000
Bayer developing Viagra competitor, launch 2002
23 March 2000
Colombian Viagra copy sales soar
13 March 2000
Eastern European news in brief
6 March 2000
Stock Commentary New York
2 March 2000
Celebrex sets record for launch
24 February 2000
Nastech's intranasal apomorhpine, more effective than Viagra?
24 February 2000
Mail pharmacy sues state Attorney General
14 February 2000
Pfizer to sue Colombia over Viagra?
31 January 2000
Pfizer EPS in 4th qtr rises 56%
18 January 2000
Vivus shares double on ALIBRA filing, new impotence drug
23 December 1999
Australia PBS probe after Pfizer challenge?
7 December 1999
Israel is the world's "fake-Viagra capital"
29 November 1999
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
